Open Access

ONLINE FIRST: Silent hypoxaemia in COVID-19. What does it mean?

Open Access

ONLINE FIRST: Silent hypoxaemia in COVID-19. What does it mean?

KATRINA O. TONGA, EMILY STONE

Figures

© DMITRII MELNIKOV/ALAMY/ DIOMEDIA. MODEL USED FOR ILLUSTRATIVE PURPOSES ONLY
© DMITRII MELNIKOV/ALAMY/ DIOMEDIA. MODEL USED FOR ILLUSTRATIVE PURPOSES ONLY
Dr Tonga is a Staff Specialist in the Department of Thoracic Medicine, St Vincent’s Hospital, Sydney; Conjoint Senior Lecturer at St Vincent’s Clinical School, UNSW Sydney, Sydney; and Lecturer at the University of Sydney, Sydney. Dr Stone is a Senior Staff Specialist in the Department of Thoracic Medicine,
 St Vincent’s Hospital, Sydney; and Conjoint Lecturer at St Vincent’s Clinical School, UNSW Sydney, Sydney, NSW.

 

Advertisement

References

1.    Coronavirus (COVID-19) current situation and case numbers. Australian Government Department of Health; Canberra; 2021. Available online at: https://www.health.gov.au/news/health-alerts/novel-coronavirus-2019-ncov-health-alert/coronavirus-covid-19-case-numbers-and-statistics#covid19-summary-statistics (accessed August 2021).
2.    Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-273.
3.    Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
4.    Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8: 475-481.
5.    Gandhi RT, Lynch JB, Del Rio C. Mild or moderate Covid-19. N Engl J Med 2020; 383: 1757-1766.
6.    Oran DP, Topol EJ. The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review. Ann Intern Med 2021; 174: 655-662.
7.    Swenson KE, Ruoss SJ, Swenson ER. The pathophysiology and dangers of silent hypoxemia in COVID-19 lung injury. Ann Am Thorac Soc 2021; 18: 1098-1105.
8.    Rahman A, Tabassum T, Araf Y, Al Nahid A, Ullah MA, Hosen MJ. Silent hypoxia in COVID-19: pathomechanism and possible management strategy. Mol Biol Rep 2021; 48: 3863-3869.
9.    Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med 2020; 201: 1299-1300.
10.    Wilkerson RG, Adler JD, Shah NG, Brown R. Silent hypoxia: a harbinger of clinical deterioration in patients with COVID-19. Am J Emerg Med 2020; 38: 2243.e5-2243.e6.
11.    Simonson TS, Baker TL, Banzett RB, et al. Silent hypoxaemia in COVID-19 patients. J Physiol 2021; 599: 1057-1065.
12.    Couzin-Frankel J. The mystery of the pandemic’s ‘happy hypoxia’. Science 2020; 368: 455-456.
13.    Ottestad W, Seim M, Maehlen JO. COVID-19 with silent hypoxemia. Tidsskr Nor Laegeforen 2020; 140.
14.    Okuhama A, Ishikane M, Hotta M, et al. Clinical and radiological findings of silent hypoxia among COVID-19 patients. J Infect Chemother 2021; 27: 1536-1538.
15.    Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med 2020; 202: 356-360.
16.    Friedman J, Calderon-Villarreal A, Bojorquez L, Hernandez CV, Schriger DL, Hirashima ET. Excess out-of-hospital mortality and declining oxygen saturation: the sentinel role of EMS data in the COVID-19 crisis in Tijuana, Mexico. Ann Emerg Med 2020; 76: 413-426.
17.    Xie J, Covassin N, Fan Z, et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc 2020; 95: 1138-1147.
18.    Brouqui P, Amrane S, Million M, et al. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int J Infect Dis 2021; 102: 233-238.
19.    Berezin L, Zhabokritsky A, Andany N, et al. Diagnostic accuracy of subjective dyspnoea in detecting hypoxaemia among outpatients with COVID-19: a retrospective cohort study. BMJ Open 2021; 11: e046282.
20.    Luks AM, Swenson ER. Pulse oximetry for monitoring patients with COVID-19 at home. Potential pitfalls and practical guidance. Ann Am Thorac Soc 2020; 17: 1040-1046.
21.    Potter VA. Pulse oximetry in general practice: how would a pulse oximeter influence patient management? Eur J Gen Pract 2007; 13: 216-220.
22.    Burki NK, Lee L-Y. Mechanisms of dyspnea. Chest 2010; 138: 1196-1201.
23.    Carsana L, Sonzogni A, Nasr A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis 2020; 20: 1135-1140.
24.    Tomashefski JF Jr, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol 1983; 112: 112-126.
25.    Mangalmurti NS, Reilly JP, Cines DB, Meyer NJ, Hunter CA, Vaughan AE. COVID-19-associated acute respiratory distress syndrome clarified: a vascular endotype? Am J Respir Crit Care Med 2020; 202: 750-753.
26.    Menter T, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology 2020; 77: 198-209.
27.    Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383: 120-128.
28.    Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region – case series. N Engl J Med 2020; 382: 2012-2022.
29.    Ziehr DR, Alladina J, Petri CR, et al. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. Am J Respir Crit Care Med 2020; 201: 1560-1564.
30.    Ramin S, Charbit J, Dagod G, Girard M, Jaber S, Capdevila X. Transpulmonary pressure in SARS-CoV-2-associated acute respiratory distress syndrome: a single-center observational study. Crit Care 2020; 24: 408.
31.    Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006; 354: 1775-1786.
32.    Guerin C, Reignier J, Richard J-C, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368: 2159-2168.
33.    Patel BV, Arachchillage DJ, Ridge CA, et al. Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations. Am J Respir Crit Care Med 2020; 202: 690-699.
34.    Grimmer B, Kuebler WM. The endothelium in hypoxic pulmonary vasoconstriction. J Appl Physiol (1985) 2017; 123: 1635-1646.
35.    Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020; 92: 552-555.
36.    Villadiego J, Ramírez-Lorca R, Cala F, et al. Is carotid body infection responsible for silent hypoxemia in COVID-19 patients? Function 2021; 2: zqaa032.
37.    Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181: 271-280.e8.
38.    Gootenberg DB, Kurtzman N, O’Mara T, et al. Developing a pulse oximetry home monitoring protocol for patients suspected with COVID-19 after emergency department discharge. BMJ Health Care Inform 2021; 28: e100330.
39.    Shang L, Lye DC, Cao B. Contemporary narrative review of treatment options for COVID-19. Respirology 2021; 26: 745-767.
40.    Paul V, Patel S, Royse M, Odish M, Malhotra A, Koenig S. Proning in non-intubated (PINI) in times of COVID-19: case series and a review. J Intensive Care Med 2020; 35: 818-824.
41.    Kharat A, Dupuis-Lozeron E, Cantero C, et al. Self-proning in COVID-19 patients on low-flow oxygen therapy: a cluster randomised controlled trial. ERJ Open Res 2021; 7: 00692-2020.